Primer: GNI Group (2160 JP) - Aug 2026
GNI Group is a biopharmaceutical company with an integrated business model focused on the high-growth Chinese market, where its flagship drug,...
94 Views
𝛼SK or SearchENTITY
GNI Group (2160 JP)
GNI Group (2160 JP)
12
Analysis
Health Care • Japan
GNI Group Ltd. develops therapeutic pharmaceutical products utilizing Genome analysis. The Company targets diseases indigenous to Asian countries. GNI controls the whole process of drug discovery by conducting clinical trials, research and development, and marketing. The Company owns global subsidiaries in China and the US.
morex